middle.news
How Is PYC Therapeutics Advancing RNA Treatments for Rare Genetic Diseases?
9:40am on Monday 27th of October, 2025 AEDT
•
Biotechnology
Read Story
How Is PYC Therapeutics Advancing RNA Treatments for Rare Genetic Diseases?
9:40am on Monday 27th of October, 2025 AEDT
Key Points
Progression in Phase 1a/1b trials for Polycystic Kidney Disease
Ongoing Phase 1/2 trials and FDA engagement for Retinitis Pigmentosa type 11
Advancement into global repeat dose studies for Autosomal Dominant Optic Atrophy
Preclinical data supporting IND-enabling studies for Phelan-McDermid Syndrome
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC
OPEN ARTICLE